Open access journal of the Ferrata-Storti Foundation, a non-profit organization
Letters to the Editor

Outcomes of ibrutinib plus lenalidomide combination in patients with large B-cell lymphoma refractory to or relapsing after CAR-T-cell therapy and who failed or were ineligible for bispecific antibodies: a multicenter real-world REALI-T study

CHU de Lyon, Lyon
Institut de Cancérologie Strasbourg Europe (ICANS), Strasbourg
Institut de Cancérologie Strasbourg Europe (ICANS), Strasbourg
Institut de Cancérologie et d’Hématologie Universitaire de Saint-Étienne, St Etienne
CHU de Besançon – Hôpital Jean Minjoz, Besancon
CHU de Besançon – Hôpital Jean Minjoz, Besancon
CHU de Bordeaux – Centre François Magendie, Bordeaux
Institut Paoli-Calmettes, Marseille, Marseille
Institut Paoli-Calmettes, Marseille, Marseille
Centre Henri Becquerel, Rouen
CHU de Poitiers, Poitiers, Poitiers
CHU de Grenoble – Hôpital Albert Michallon, Grenoble
CHU de Lille – Hôpital Claude Huriez, Lille
CHU de Lyon, Lyon
CHU de Lyon, Lyon
CHU de Lyon, Lyon
CHU de Lyon, Lyon
CHU de Lyon, Lyon
CHU de Lyon, Lyon
CHU de Lyon, Lyon
Haematologica Early view Oct 15, 2026 https://doi.org/10.3324/haematol.2026.300868

Abstract

Not available.

Figures & Tables

Article Information

Early view : Letters to the Editor
 
DOI
https://doi.org/10.3324/haematol.2026.300868
Pubmed
42876292
 
Published
2026-10-15
Published By
Ferrata Storti Foundation, Pavia, Italy
Print ISSN
0390-6078
Online ISSN
1592-8721
 
Copyright & Usage
Copyright (c) 2026 Ferrata Storti Foundation
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Article Usage

Online Views
169
PDF Downloads
81
No Data
PlumX
Navigate
For Authors
For Reviewers
For Advertisers
Education
Privacy
More
Copyright © 2026 by the Ferrata Storti Foundation | Web design ￫ | Development ￫
ISSN 0390-6078 print | ISSN 1592-8721 online